SUBSCRIBE
SUBSCRIBE

Press Releases

Browse the the latest press releases from around the industry. Want to filter press releases by date, keyword, and more? Search here.

THE LATEST
Press Releases
L7 Informatics and Turnberry Solutions Announce Strategic Teaming Agreement to Accelerate Life Sciences Innovation at Enterprise Scale
Collaboration combines AI-ready data platforms with delivery certainty to help life sciences and food companies move faster, from strategy to measurable outcomes.
January 8, 2026
 · 
1 min read
Press Releases
BioVaxys Announces Phase 1 Clinical Study Results Advancing DPX(TM)-Formulated Products in Patients with Non-Muscle Invasive Bladder Cancer
January 8, 2026
 · 
9 min read
Press Releases
MustGrow Announces Non-Brokered LIFE Offering of up to $2 Million
January 8, 2026
 · 
7 min read
Press Releases
Nona Biosciences Expands Integrated Capabilities following Early Clinical Services, Modality Solutions, and AI Platform-Driven Growth Strategy
January 8, 2026
 · 
1 min read
Press Releases
32 Biosciences to Launch $40 Million Series A at J.P. Morgan to Advance First-in-Class GI Mucosal-Immune Therapeutics
January 8, 2026
 · 
4 min read
Press Releases
Xencor Highlights Corporate Priorities and 2026 Pipeline Milestones
January 8, 2026
 · 
7 min read
Press Releases
Cellarity Provides Strategic Priorities and Outlook for 2026
January 8, 2026
 · 
4 min read
Press Releases
Personalis Reports Select Preliminary Fourth Quarter and Full Year 2025 Results and Recent Highlights
January 8, 2026
 · 
8 min read
Press Releases
Coya Therapeutics Announces Results of Investigator-Initiated Study of LD IL-2 and CTLA4-Ig Demonstrating Treg Enhancement and Cognitive Stability in Frontotemporal Dementia Patients
January 8, 2026
 · 
8 min read
Press Releases
858 Therapeutics Announces FDA Fast Track Designation for PARG Inhibitor ETX-19477 for the Treatment of Patients with BRCA-Mutated, Platinum-Resistant Ovarian Cancer
January 8, 2026
 · 
2 min read
Press Releases
Frazier Life Sciences Announces Multiple Promotions to Key Senior Level Positions
January 8, 2026
 · 
3 min read
Press Releases
Charles River Laboratories Announces Planned Retirement of James C. Foster and CEO Succession Plan
January 8, 2026
 · 
11 min read
Press Releases
Spruce Biosciences Secures Up to $50 Million in Growth Capital from Avenue Capital
January 8, 2026
 · 
5 min read
Press Releases
Ukko Provides 2026 Strategic Outlook and Highlights Recent Milestones
January 8, 2026
 · 
3 min read
Press Releases
Epirium Bio Announces Follow-on Phase 1 Results in Older Adult Participants for MF-300, a First-In-Class, Oral 15-PGDH Enzyme Inhibitor, for the Treatment of Sarcopenia
January 8, 2026
 · 
4 min read
Press Releases
Avenacy Provides Update on Business Progress and Announces 2026 Strategic Priorities Ahead of 44th Annual J.P. Morgan Healthcare Conference
January 8, 2026
 · 
6 min read
Press Releases
JCR Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 8, 2026
 · 
2 min read
Press Releases
INTENT Biologics Receives FDA Fast Track Designation for PEP Biologic™
January 8, 2026
 · 
4 min read
Press Releases
Gordian Bio Announces Research Collaboration with Pfizer to Accelerate In Vivo Target Discovery in Obesity
January 8, 2026
 · 
2 min read
Press Releases
Fox Chase Cancer Center and Arima Genomics Partner to Advance 3D Genome Diagnostics for Cancer Care
January 8, 2026
 · 
5 min read
Press Releases
BostonGene Announces Collaboration with Ottimo Pharma to Optimize and Accelerate Development of First-in-Class PD-1/VEGFR2 Immuno-Oncology Therapy Using AI
January 8, 2026
 · 
3 min read
Press Releases
Candid Therapeutics Plans to Initiate Multiple Phase 2 Studies Following Promising Clinical Data of T-cell Engagers in Autoimmune Diseases
January 8, 2026
 · 
3 min read
Press Releases
VectorY Therapeutics Receives FDA Fast Track Designation for VTx-002, a First-in-Class Vectorized Antibody Targeting Underlying Disease Biology in ALS
January 8, 2026
 · 
3 min read
Press Releases
Parabilis Medicines Announces Oversubscribed $305 Million Financing to Support Ongoing FOG-001 (zolucatetide) Clinical Development Across a Broad Range of Tumors and Advance Pioneering Pipeline and Helicon Platform
January 8, 2026
 · 
5 min read
Press Releases
DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years
December 17, 2025
 · 
10 min read
Press Releases
FibroBiologics Announces Closing of $1.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
December 17, 2025
 · 
5 min read
Press Releases
MAIA Biotechnology Announces $1.51 Million Private Placement
December 17, 2025
 · 
4 min read
Press Releases
Orchard Therapeutics Celebrates Addition of Metachromatic Leukodystrophy to the U.S. Recommended Uniform Screening Panel
December 17, 2025
 · 
9 min read
Press Releases
Humanetics Corporation Appoints Timothy E. Morris as Chief Operating Officer
December 17, 2025
 · 
2 min read
Press Releases
CytoAgents Appoints Dr. Johannes Wolff as Chief Medical Officer and Michael Howell as Chief Scientific Officer
December 17, 2025
 · 
3 min read
Press Releases
Thermedical Announces First Patient Treated in Pivotal Clinical Study Evaluating SERF Ablation for Life-Threatening Ventricular Tachycardia
December 17, 2025
 · 
4 min read
Press Releases
Vyriad Unveils Lead In Vivo CAR T Candidate VV169 and Data Supporting Future Clinical Development During ASH 2025
December 17, 2025
 · 
4 min read
Press Releases
ANKTIVA® with BCG Demonstrates 96% Survival from Bladder Cancer at Three Years with Median Survival Not Yet Reached in BCG-Unresponsive High-Grade Papillary-Only Non-Muscle Invasive Bladder Cancer
December 17, 2025
 · 
11 min read
Press Releases
Oncolytics Biotech® Announces Promising Efficacy and Translational Data Supporting Pelareorep in KRAS-Mutant Metastatic Colorectal Cancer
December 17, 2025
 · 
6 min read
Load More